Artwork

Sisällön tarjoaa Jon Chee. Jon Chee tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

🧬 Mark Kotter - bit.bio - Part 3 | Success in Academia vs. Industry | Vital Things All Founders Should Know | The Importance of Company Culture | bit.bio & the Operating System of Life

25:13
 
Jaa
 

Manage episode 425359821 series 3461709
Sisällön tarjoaa Jon Chee. Jon Chee tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 3 of 4.

My guest for this week’s episode is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and founder of bit.bio. Bit.bio is an award-winning human synthetic biology company providing human cells for research, drug discovery, and cell therapy. Bit.bio applies a patented safe harbor gene targeting approach to inducibly express transcription factor combinations that reprogram human-induced pluripotent stem cells into highly defined and mature human cell types. Bit.bio spun out of the University of Cambridge in 2016 and has since raised approximately $200 million from Arch Ventures, Foresight Capital, Milky Way, Charles River Laboratories, National Resilience, Tencent, and Pulau Capital, among others.

In addition to bit.bio, Mark is also the co-founder of Meatable, scientific founder and chairman of rejuvenation startup clock.bio, and co-founder and trustee of Myelopathy.org, the first charity dedicated to a common yet often overseen condition causing a slow-motion spinal cord injury. Mark has also been a professor and researcher at Cambridge for more than 15 years. His diverse experience as an academic and serial entrepreneur offers a wealth of insights aspiring scientist founders can draw from.

Join us this week and hear about:
  • Gene expression discoveries and the technology bit.bio is developing around them
  • Vital questions and concepts that every founder should know before they start developing their company
  • The benefits of founder-led companies and their relentless focus on their mission
  • And much more!

Please enjoy my conversation with Mark Kotter.
Timestamps:
00:28 Intro
01:55 Explaining the technology they developed while at the stem cell institute
03:26 An unexpected gene expression discovery and dealing with the issues that followed
05:32 Comparing what it means to be successful in academia vs industry
06:53 The dangers of having a misalignment of objectives while building a company and other lessons learned by Mark
10:18 Vital things that founders need to address before taking their idea from the lab and building a company around it
14:08 How Mark and his COO’s skill sets compliment each other
15:29 The importance of company culture and how it can affect both building a company and investing in one
17:55 Benefits to the relentless objective-based focus that some founder-led companies have over professionally managed ones
19:44 Parallels between Excedr’s all-in origins and bit.bio’s complete dedication to its mission
21:47 What Mark’s operating system of life is, what are its applications, and why it fuels bit.bio’s culture
24:07 Outro

Find Our Guest, Mark Kotter, at these links:

Find Our Host, Jon Chee, at these links:

Social & Website
Enriched Notes:

Topics Mentioned:
Cambridge Stem Cell Institute https://www.stemcells.cam.ac.uk/
University of Cambridge https://www.cam.ac.uk/

Single Cell Analysis: Considerations & Applications
Lab Equipment for Genetic Engineering Research
What is Live-Cell Imaging & How Does It Work?
Common Lab Equipment for Life Sciences Research in 2024 https://www.excedr.com/blog/common-lab-equipment

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

76 jaksoa

Artwork
iconJaa
 
Manage episode 425359821 series 3461709
Sisällön tarjoaa Jon Chee. Jon Chee tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 3 of 4.

My guest for this week’s episode is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and founder of bit.bio. Bit.bio is an award-winning human synthetic biology company providing human cells for research, drug discovery, and cell therapy. Bit.bio applies a patented safe harbor gene targeting approach to inducibly express transcription factor combinations that reprogram human-induced pluripotent stem cells into highly defined and mature human cell types. Bit.bio spun out of the University of Cambridge in 2016 and has since raised approximately $200 million from Arch Ventures, Foresight Capital, Milky Way, Charles River Laboratories, National Resilience, Tencent, and Pulau Capital, among others.

In addition to bit.bio, Mark is also the co-founder of Meatable, scientific founder and chairman of rejuvenation startup clock.bio, and co-founder and trustee of Myelopathy.org, the first charity dedicated to a common yet often overseen condition causing a slow-motion spinal cord injury. Mark has also been a professor and researcher at Cambridge for more than 15 years. His diverse experience as an academic and serial entrepreneur offers a wealth of insights aspiring scientist founders can draw from.

Join us this week and hear about:
  • Gene expression discoveries and the technology bit.bio is developing around them
  • Vital questions and concepts that every founder should know before they start developing their company
  • The benefits of founder-led companies and their relentless focus on their mission
  • And much more!

Please enjoy my conversation with Mark Kotter.
Timestamps:
00:28 Intro
01:55 Explaining the technology they developed while at the stem cell institute
03:26 An unexpected gene expression discovery and dealing with the issues that followed
05:32 Comparing what it means to be successful in academia vs industry
06:53 The dangers of having a misalignment of objectives while building a company and other lessons learned by Mark
10:18 Vital things that founders need to address before taking their idea from the lab and building a company around it
14:08 How Mark and his COO’s skill sets compliment each other
15:29 The importance of company culture and how it can affect both building a company and investing in one
17:55 Benefits to the relentless objective-based focus that some founder-led companies have over professionally managed ones
19:44 Parallels between Excedr’s all-in origins and bit.bio’s complete dedication to its mission
21:47 What Mark’s operating system of life is, what are its applications, and why it fuels bit.bio’s culture
24:07 Outro

Find Our Guest, Mark Kotter, at these links:

Find Our Host, Jon Chee, at these links:

Social & Website
Enriched Notes:

Topics Mentioned:
Cambridge Stem Cell Institute https://www.stemcells.cam.ac.uk/
University of Cambridge https://www.cam.ac.uk/

Single Cell Analysis: Considerations & Applications
Lab Equipment for Genetic Engineering Research
What is Live-Cell Imaging & How Does It Work?
Common Lab Equipment for Life Sciences Research in 2024 https://www.excedr.com/blog/common-lab-equipment

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

76 jaksoa

Alle episoder

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas